277 related articles for article (PubMed ID: 27148941)
21. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
22. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
[TBL] [Abstract][Full Text] [Related]
23. Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: A case report.
Wang YD; Wu LL; Ma LY; Shang XB; Li ZY; Wang W; Shen C; Yang JJ; Sun LX; Zhao CY
Medicine (Baltimore); 2019 Jan; 98(2):e14032. PubMed ID: 30633196
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus B19-associated hemophagocytic lymphohistiocytosis in a child with precursor B-cell acute lymphoblastic leukemia under maintenance chemotherapy.
Matsubara K; Uchida Y; Wada T; Iwata A; Yura K; Kamimura K; Nigami H; Fukaya T
J Pediatr Hematol Oncol; 2011 Oct; 33(7):565-9. PubMed ID: 21617562
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
Pan H; Feng DN; Song L; Sun LR
BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
[TBL] [Abstract][Full Text] [Related]
26. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis.
Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T
J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211
[TBL] [Abstract][Full Text] [Related]
27. Clinically Mild Encephalitis/Encephalopathy With a Reversible Splenial Lesion Accompanied by Epstein-Barr Virus Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature.
Yamaguchi H; Ishida T; Yokoi T; Tanaka T; Maruyama A; Nagase H; Hasegawa D; Imadome KI; Takeda H; Kosaka Y; Uetani Y
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e92-e96. PubMed ID: 27879539
[TBL] [Abstract][Full Text] [Related]
28. Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
Batra R; Medeiros BC; Zehnder JL; Warnke RA; Natkunam Y
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):325-30. PubMed ID: 22505014
[TBL] [Abstract][Full Text] [Related]
29. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
Lee JS; Kang JH; Lee GK; Park HJ
J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
[TBL] [Abstract][Full Text] [Related]
31. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
Song Y; Wang Y; Wang Z
Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
[TBL] [Abstract][Full Text] [Related]
32. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus-positive diffuse large B-cell lymphoma, NOS of bone marrow-liver-spleen type: an autopsy case report.
Iizuka H; Mori Y; Iwao N; Koike M; Noguchi M
J Clin Exp Hematop; 2021 Jun; 61(2):102-108. PubMed ID: 33994430
[TBL] [Abstract][Full Text] [Related]
33. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H
Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400
[TBL] [Abstract][Full Text] [Related]
34. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010.
Imashuku S
J Pediatr Hematol Oncol; 2011 Jan; 33(1):35-9. PubMed ID: 21088619
[TBL] [Abstract][Full Text] [Related]
36. B-Cell lymphoproliferative disorder not associated with Epstein-Barr Virus in a child with relapsed acute lymphoblastic leukemia.
Lehrnbecher T; Trusen A; Deinlein F; Höcht B; Marx A; Kühl J
Med Pediatr Oncol; 2003 Jan; 40(1):13-7. PubMed ID: 12426680
[TBL] [Abstract][Full Text] [Related]
37. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
[TBL] [Abstract][Full Text] [Related]
38. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
Bonney DK; Htwe EE; Turner A; Kelsey A; Shabani A; Hughes S; Hughes I; Wynn RF
Pediatr Blood Cancer; 2012 Mar; 58(3):459-61. PubMed ID: 21584931
[TBL] [Abstract][Full Text] [Related]
39. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
[TBL] [Abstract][Full Text] [Related]
40. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection.
Meng GQ; Wang JS; Wang YN; Wei N; Wang Z
Int Immunopharmacol; 2021 Jul; 96():107606. PubMed ID: 33826999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
